Anavex Life Sciences Corp reports results for the quarter ended in June - Earnings Summary

Anavex Life Sciences

06/08/2024 14:52

* Anavex Life Sciences Corp  AVXL.OQ  reported a quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
June, identical to the same quarter last year.  The mean
expectation of three analysts for the quarter was for a loss
of 16 cents per share. Wall Street expected results to range
from -21 cents to -12 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Anavex Life Sciences Corp's reported EPS for the quarter
was a
loss of 14 cents​.
    * The company reported a quarterly loss of $12.21 million.
    * Anavex Life Sciences Corp shares had risen by 52.8% this
quarter and lost 30.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 33.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Anavex Life
Sciences Corp is $40.45 
This summary was machine generated from LSEG data August 6 at
01:52 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.16          -0.14          Beat
 Mar. 31 2024      -0.11          -0.13          Missed
 Dec. 31 2023      -0.14          -0.11          Beat
 Sep. 30 2023      -0.15          -0.12          Beat